<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36974333</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2468-2276</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Scientific African</Title><ISOAbbreviation>Sci Afr</ISOAbbreviation></Journal><ArticleTitle>Herbal supplements as treatment options for COVID-19: A call for clinical development of herbal supplements for emerging and re-emerging viral threats in Sub-Saharan Africa.</ArticleTitle><Pagination><StartPage>e01627</StartPage><MedlinePgn>e01627</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.sciaf.2023.e01627</ELocationID><Abstract><AbstractText>The advent of Corona virus Disease 2019 (COVID-19) distorted health systems of many countries. Efforts have been made to either develop new treatment solutions such as vaccines or repurpose previously adopted drugs. Challenges in accessing available treatment, inadequate, non-existent, or overstretched healthcare facilities, long COVID disease, cultural practices and beliefs about vaccination, vaccine hesitancy, availability, accessibility and perceived safety of herbal supplements seem to be major factors propelling individuals to use herbal supplements. Published reports advocating for clinical development of herbal supplements for COVID-19 and other emerging and re-emerging viral diseases are sparse. This paper aims to review the pathogenesis of COVID-19, use of herbal products during the pandemic and make case for clinical development of herbal supplements through the adoption of modern and acceptable technologies and research processes. This was a scoping review. Database searches of Google Scholar, PubMed and ResearchGate among others were performed using related keywords to identify relevant journals and lists of primary articles. Clinical trial databases:-Clinicaltrial.gov, Pan African Clinical Trial Registry (PACTR) and WHO international clinical trial registry (ICTRP) were reviewed to extract data. The use of herbal supplements during COVID-19 was not only peculiar to individuals living in Sub-Saharan Africa, but a global practice. Herbal supplements recommended to manage COVID-19 have not been validated using clinical trials. Available data showed that the number of herbal supplements undergoing clinical trial for COVID-19 indication in Africa was low. The availability of medicinal plants in Sub-Saharan Africa if well explored has great potentials to address various emerging and re-emerging viral diseases confronting the region. The economic potential of clinically validated herbal supplements are huge, and tapping into this opportunity created by preference of population to herbal supplement could increase export of herbal supplement and gross domestic product (GDP) of respective countries in Africa.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Onyeaghala</LastName><ForeName>Augustine Anayochukwu</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Unit of Clinical Chemistry, Department of Medical Laboratory Science, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit of Clinical Chemistry, Department of Medical Laboratory Science, Chrisland University, Owode, Abeokuta, Ogun State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anyiam</LastName><ForeName>Arinze Favour</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science, Thomas Adewumi University, Oko, Kwara State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husaini</LastName><ForeName>Danladi Chiroma</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Allied Health (Pharmacy), Faculty of Health Sciences, University of Belize, Central America, Belize.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onyeaghala</LastName><ForeName>Emmanuella Ogechi</ForeName><Initials>EO</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science, Achievers University, Owo, Ondo State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obi</LastName><ForeName>Ejeatuluchukwu</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, Faculty of Basic Clinical Science, College of Health Science, Nnamdi Azikiwe University, Nnewi, Campus, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Sci Afr</MedlineTA><NlmUniqueID>101771789</NlmUniqueID><ISSNLinking>2468-2276</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical Development</Keyword><Keyword MajorTopicYN="N">Herbal Medicine</Keyword><Keyword MajorTopicYN="N">Herbal Products</Keyword><Keyword MajorTopicYN="N">Herbal Supplements</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36974333</ArticleId><ArticleId IdType="pmc">PMC9985929</ArticleId><ArticleId IdType="doi">10.1016/j.sciaf.2023.e01627</ArticleId><ArticleId IdType="pii">S2468-2276(23)00084-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu B., Guo H., Zhou P.S.Z. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19(3):141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Sadr W.M., Justman J. Africa in the path of Covid-19. N. Engl. J. Med. 2020;383(3):e11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32302075</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachega J., Seydi M., Zumla A. The late arrival of coronavirus disease 2019 (COVID-19) in Africa: mitigating pan-continental spread. Clin. Infect. Dis. 2020;71(15):875&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184327</ArticleId><ArticleId IdType="pubmed">32227121</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, Declaration of alma-ata. (1978). Available at: https://www.who.int/teams/social-determinants-of-health/declaration-of-alma-ata. Retrieved September 30, 2022.</Citation></Reference><Reference><Citation>Mattey-Mora P.P., Begle C.A., Owusu C.K., Chen C., Parker M.A. Hospitalised versus outpatient COVID-19 patients&#x2019; background characteristics and comorbidities: a systematic review and meta-analysis. Rev. Med. Virol. 2022;32(3) doi: 10.1002/rmv.2306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2306</ArticleId><ArticleId IdType="pmc">PMC8646852</ArticleId><ArticleId IdType="pubmed">34674338</ArticleId></ArticleIdList></Reference><Reference><Citation>Dastenae Z.H., Bahadori A., Dehghani M., Asadi-samani M., Izadi I., Shahraki H.R. Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19&#xa0;: a randomized clinical trial R. Int. J. Infect. Dis. 2022;122:659&#x2013;664. doi: 10.1016/j.ijid.2022.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.07.019</ArticleId><ArticleId IdType="pmc">PMC9270180</ArticleId><ArticleId IdType="pubmed">35817286</ArticleId></ArticleIdList></Reference><Reference><Citation>Haleem A., Javaid M., Vaishya R. Effects of COVID 19 pandemic in daily life. Curr. Med. Res. Pract. 2020 doi: 10.1016/j.cmrp.2020.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmrp.2020.03.011</ArticleId><ArticleId IdType="pmc">PMC7147210</ArticleId><ArticleId IdType="pubmed">32292804</ArticleId></ArticleIdList></Reference><Reference><Citation>Intawong K., Olson D., Chariyalertsak S. Application technology to fight the COVID-19 pandemic: lessons learned in Thailand. Biochem. Biophys. Res. Commun. 2021;538:231&#x2013;237. doi: 10.1016/j.bbrc.2021.01.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.01.093</ArticleId><ArticleId IdType="pmc">PMC7880622</ArticleId><ArticleId IdType="pubmed">33589143</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (2020). Coronavirus disease (COVID-19) advice for the public. Avaiable at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. Accessed 16th August, 2022.</Citation></Reference><Reference><Citation>Chari A., Samur M.K., Martinez-Lopez J., et al. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the international Myeloma society data set. Blood. 2020;136:3033&#x2013;3040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7759145</ArticleId><ArticleId IdType="pubmed">33367546</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). (2022). Johns Hopkins coronavirus resource center. https://coronavirus.jhu.edu/map.html. Accessed 20th August, 2022.</Citation></Reference><Reference><Citation>Goga A., Bekker L., Garrett N., Reddy T., Yende-Zuma N., Fairall L., Moultrie H., Takalani A., Trivella V., Faesen M., Bailey V., Seocharan I.G.G. Breakthrough SARSCoV-2 infections during periods of delta and omicron predominance, South Africa. Lancet. 2022;400:269&#x2013;271. doi: 10.1016/S0140-6736(22)01190-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01190-4</ArticleId><ArticleId IdType="pmc">PMC9259009</ArticleId><ArticleId IdType="pubmed">35809579</ArticleId></ArticleIdList></Reference><Reference><Citation>Yashika G., Sujeet K., Mishra&#x2019; H.R., Jyotika G., Ravi K., Shakya SK., Vipin K.J., Babu G., Arjun G., Ravindra S., Rabinarayan S., Vijay K A. Phytomedicines explored under in vitro and in-silico studies against coronavirus: An opportunity to develop traditional medicines. S. Afr. J. Bot. 2022;16:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057940</ArticleId><ArticleId IdType="pubmed">35530267</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese A., Gambardella J., Sardu C.S.G. miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines. 2020;8:462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693865</ArticleId><ArticleId IdType="pubmed">33143053</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Wang Y., Shao C., Huang J., Gan J., Huang X., et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27:1451&#x2013;1454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091918</ArticleId><ArticleId IdType="pubmed">32205856</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J., Spittle D.A. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021;76:412&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S., Aphinyanaphongs Y., Jones S., Iturrate E., Hochman J., Berger J.S. Thrombosis in hospitalized patients with COVID-19 in a New York City health system. JAMA. 2020;324(8):799. doi: 10.1001/jama.2020.13372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13372</ArticleId><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J., Patone M., Mei X.W., et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:1931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8388189</ArticleId><ArticleId IdType="pubmed">34446426</ArticleId></ArticleIdList></Reference><Reference><Citation>Modin D., Claggett B., Sindet-Pedersen C., et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation. 2020;142:2080&#x2013;2082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682795</ArticleId><ArticleId IdType="pubmed">33054349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannoni S., de Groot R., Bell S., Markus H.S. Stroke in COVID-19: a systematic review and meta-analysis. Int. J. Stroke. 2020;16(2):137&#x2013;149. doi: 10.1177/1747493020972922. 2021 FebEpub 2020 Nov 11. PMID: 33103610; PMICID: PMC7859578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493020972922</ArticleId><ArticleId IdType="pmc">PMC7859578</ArticleId><ArticleId IdType="pubmed">33103610</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.K., Mainbourg S., Friggeri A., et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax. 2021;76:970&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pubmed">33622981</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Tracking SARS-Cov-2 variants). Available at: https://www.who.int/activities/tracking-SARS-Cov-2-variants. Accessed on August 24, 2022</Citation></Reference><Reference><Citation>Callaway E. Omicron likely to weaken COVID vaccine protection. Sci. Am. 2021;600(7889):367&#x2013;368. doi: 10.1038/d41586-021-03672-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03672-3</ArticleId><ArticleId IdType="pubmed">34880488</ArticleId></ArticleIdList></Reference><Reference><Citation>T. Isabelle (2022). Long COVID is still raising more questions than answers, say researchers. Available at: https://www.sciencealert.com/long-covid-is-still-raising-more-questions-than-answers-say-researchers. Accessed 20th September, 2022.</Citation></Reference><Reference><Citation>Wilhelm A., Widera M., Grikscheit K., et al. MedRxiv; 2021. Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.07.21267432</ArticleId></ArticleIdList></Reference><Reference><Citation>Orisakwe O.E., Orish C.N., Nwanaforo E.O. Vol. 10. 2020. Coronavirus disease (COVID-19) and Africa: acclaimed home remedies; p. e00620. (Sci. Afr.).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sciaf.2020.e00620</ArticleId><ArticleId IdType="pmc">PMC7605786</ArticleId><ArticleId IdType="pubmed">33163740</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute for Health Metrics and Evaluation (2022). WHO: At least 17 million people in the WHO European Region experienced long COVID in the first two years of the pandemic; millions may have to live with it for years to come. Available at https://www.healthdata.org/news-release/who-least-17-million-people-who-european-region-experienced-long-covid-first-two-years. Accessed 29th September, 2022.</Citation></Reference><Reference><Citation>Ludwig H., Sonneveld P., Boccadoro M., Terpos E. Covid-19 and Myeloma. HemaSphere. 2022;6:5&#x2013;6. doi: 10.1097/01.hs9.0000829540.80501.f8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.hs9.0000829540.80501.f8</ArticleId></ArticleIdList></Reference><Reference><Citation>P. Mathur &amp; S. Kottilil (2022). Immunomodulatory therapies for COVID-19. 19:1&#x2013;10. 10.3389/fmed.2022.921452</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9381694</ArticleId><ArticleId IdType="pubmed">35991665</ArticleId></ArticleIdList></Reference><Reference><Citation>Collie S., Champion J., Moultrie H., Bekker L.G. Effectiveness of BNT162b2 vaccine against omicron variant in South Africa. N. Engl. J. Med. 2022;386:494&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757569</ArticleId><ArticleId IdType="pubmed">34965358</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulliam J., van Schalkwyk C., Govender N., et al. MedRxiv; 2021. Increased Risk of SARS-CoV-2 Reinfection Associated With Emergence of the Omicron Variant in South Africa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.11.21266068</ArticleId><ArticleId IdType="pmc">PMC8995029</ArticleId><ArticleId IdType="pubmed">35289632</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., McGettigan J., Khetan S., Segall N., Solis J., Brosz A., Fierro C., Schwartz H., Neuzil K., Corey L., Zaks T. Efficacy and safety of the mrna-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 2021;384(5):403&#x2013;416. doi: 10.1056/nejmoa2035389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Young-Xu Y., Korves C., Roberts J., et al. Coverage and estimated effectiveness of mRNA COVID-19 vaccines among US veterans. JAMA Netw. Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8495523</ArticleId><ArticleId IdType="pubmed">34613401</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S.J., Moreira E.D., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. N. Engl. J. Med. 2021;385:1761&#x2013;1773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461570</ArticleId><ArticleId IdType="pubmed">34525277</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz E.A, Richterman A., Gandhi R.T.S.P. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann. Intern Med. 2021;174(1):69&#x2013;79. doi: 10.7326/M20-5008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5008</ArticleId><ArticleId IdType="pmc">PMC7505025</ArticleId><ArticleId IdType="pubmed">32941052</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallapaty S. Delta threatens rural regions that dodged earlier COVID waves. Nature. 2021;596:325&#x2013;326. doi: 10.1038/d41586-021-02146-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-02146-w</ArticleId><ArticleId IdType="pubmed">34354278</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer G.O., Leland R.J. Making vaccines available to other countries before offering domestic booster vaccinations. JAMA. 2021;326:903&#x2013;904. doi: 10.1001/jama.2021.13226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.13226</ArticleId><ArticleId IdType="pubmed">34382999</ArticleId></ArticleIdList></Reference><Reference><Citation>M. Chukwuma (2022). Nigeria's slow, tedious road to herbal medicine development. The Guradian Newapaper available at https://guardian.ng/features/nigerias-slow-tedious-road-to-herbal-medicine-development/. Accessed on 10th September.</Citation></Reference><Reference><Citation>Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014;10(4):177. doi: 10.3389/fphar.2013.00177. PMID: 24454289; PMCID: PMC3887317.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2013.00177</ArticleId><ArticleId IdType="pmc">PMC3887317</ArticleId><ArticleId IdType="pubmed">24454289</ArticleId></ArticleIdList></Reference><Reference><Citation>Antwi-Baffour S.S. The place of traditional medicine in the African Society: the science, acceptance and support. Am. J. Health Res. 2014;2(2):49. doi: 10.11648/j.ajhr.20140202.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.11648/j.ajhr.20140202.13</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordling L.  Science Magazine; 2020. Unproven herbal remedy against COVID-19 could fuel drug resistant malaria, scientists warn.https://www.sciencemag.org/news/2020/05/unproven-herbalremedy-againstcovid-19-could-fuel-drug-resistant-malaria-scientists May 6 2020. Available at. Accessed 16 July, 2022.</Citation></Reference><Reference><Citation>Wikipedia. Covid-organics. 2020. [Available from: https://en.wikipedia.org/wiki/Covid-Organics. Accessed: 6 July, 2022</Citation></Reference><Reference><Citation>Xinhuanet News. Nigeria unveils drugs for treatment of Ebola, malaria 2018.Available at: http://www.xinhuanet.com/english/2018-01/20/c_1369092 97.htm. Accessed: 10 August, 2022</Citation></Reference><Reference><Citation>The Center of Awareness Food Supplement. CoA mixture 2020. Available at: https://www.coadrugs.org/coamixture/. Accessed: 12 July, 2022.</Citation></Reference><Reference><Citation>Onyeaghala A.A., Onyeaghala C.P.B.E.O., Olubiyi O.O, Attah F.A. Management of mild and moderate symptoms of COVID-19 in infected subjects using combi-5 herbal supplement: case series. J. Med. Lab. Sci. 2022;32(1) 56-6.</Citation></Reference><Reference><Citation>Onyeaghala A.A., Onyeaghala E.O., Babalola C.P., Aina O.O., Jelpe D. Herbal supplement (combi-5) in the management of COVID 19 individual with mild to moderate symptoms: A case report. J. Complement. Integr. Med. 2021;18(4):865&#x2013;867. doi: 10.1515/jcim-2020-0430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jcim-2020-0430</ArticleId><ArticleId IdType="pubmed">33962499</ArticleId></ArticleIdList></Reference><Reference><Citation>Chikowe I., Mtewa A.G., Tembo D., Smith D., Ibrahim E., Mwamatope B., Nkhungulu J., Kumpalume P., Maroyi A. Potential of Malawi's medicinal plants in COVID-19 disease management: a review. Malawi Med. J. J. Med. Assoc. Malawi. 2021;33(2):85&#x2013;107. doi: 10.4314/mmj.v33i2.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/mmj.v33i2.4</ArticleId><ArticleId IdType="pmc">PMC8560350</ArticleId><ArticleId IdType="pubmed">34777704</ArticleId></ArticleIdList></Reference><Reference><Citation>Musoke P., Nantaayi B., Ndawula Kato R., Wannyana B., Ssewante N., Wekha G., Olum R., Nakyagaba L., Rhoda Nassozi D., Nabukeera G., Marvin Kanyike A., Ojilong D., Madut Akech G., Kajjimu J., Kiwumulo J., Agira D., Okot J., Bongomin F. Fear of covid-19 and the media influence on herbal medication use in Uganda: a cross-sectional study. Risk Manag. Healthc. Policy. 2021;14:3965&#x2013;3975. doi: 10.2147/rmhp.s332325. Volume.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/rmhp.s332325</ArticleId><ArticleId IdType="pmc">PMC8464377</ArticleId><ArticleId IdType="pubmed">34584474</ArticleId></ArticleIdList></Reference><Reference><Citation>El Alami A., Fattah A., Abderrahman C. Medicinal plants used for the prevention purposes during the COVID-19 pandemic in Morocco. J. Anal. Sci. Appl. Biotechnol. 2020;2 doi: 10.48402/IMIST.PRSM/jasab-v2i1.21056.</Citation><ArticleIdList><ArticleId IdType="doi">10.48402/IMIST.PRSM/jasab-v2i1.21056</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendezu-Quispe G., Benites-Meza J.K., Urrunaga-Pastor D., Herrera-A&#xf1;azco P., Uyen-Cateriano A., Rodriguez-Morales A.J., Toro-Huamanchumo C.J., Hernandez A.V., Benites-Zapata V.A. Consumption of herbal supplements or homeopathic remedies to prevent COVID-19 and intention of vaccination for covid-19 in Latin America and the Caribbean. Trop. Med. Infect. Dis. 2022;7(6):95. doi: 10.3390/tropicalmed7060095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7060095</ArticleId><ArticleId IdType="pmc">PMC9229216</ArticleId><ArticleId IdType="pubmed">35736974</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes P., Martins L., Gomes E., Muribeca A., Pamplona S., Komesu A., Bichara C., Rai M., Silva C., Silva M. Antiviral plants from Maraj&#xf3; Island, Brazilian amazon: a narrative review. Molecules. 2022;27(5):1542. doi: 10.3390/molecules27051542. Basel, Switzerland.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27051542</ArticleId><ArticleId IdType="pmc">PMC8911695</ArticleId><ArticleId IdType="pubmed">35268642</ArticleId></ArticleIdList></Reference><Reference><Citation>Husaini D.C., Orisakwe O.E., Mphuthi D.D., Garba M.S., Obasi C.N., Nwachukwu I.E. Phytotherapies for COVID-19 in Latin America and the Caribbean (LAC): implications for present and future pandemics. Arab. Gulf J. Sci. Res. 2023 doi: 10.1108/AGJSR-08-2022-0144. 2023[Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/AGJSR-08-2022-0144</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano-Santana P.I., Pe&#xf1;arreta Tivillin J.P., Ch&#xf3;ez-Guaranda I.A., Barrag&#xe1;n Lucas A.D., Orellana-Manzano A.K., Rastrelli L. Potential bioactive compounds of medicinal plants against new coronavirus (SARS-CoV-2): a Review. Bionatura. 2021;6(1):1653&#x2013;1658. doi: 10.21931/rb/2021.06.01.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.21931/rb/2021.06.01.30</ArticleId></ArticleIdList></Reference><Reference><Citation>Villena-Tejada M., Vera-Ferchau I., Cardona-Rivero A., Zamalloa-Cornejo R., Quispe-Florez M., Frisancho-Trive&#xf1;o Z., et al. Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: a cross-sectional survey. PLoS One. 2021;16(9) doi: 10.1371/journal.pone.0257165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257165</ArticleId><ArticleId IdType="pmc">PMC8457479</ArticleId><ArticleId IdType="pubmed">34550994</ArticleId></ArticleIdList></Reference><Reference><Citation>AlNajrany S.M., Asiri Y., Sales I., AlRuthia Y. The commonly utilized natural products during the COVID-19 pandemic in Saudi Arabia: a cross-sectional online survey. Int. J. Environ. Res. Public Health. 2021;18(9):4688. doi: 10.3390/ijerph18094688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18094688</ArticleId><ArticleId IdType="pmc">PMC8125191</ArticleId><ArticleId IdType="pubmed">33924884</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wang L., Ren L. Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection. Virus Res. 2020;286 doi: 10.1016/j.virusres.2020.198073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198073</ArticleId><ArticleId IdType="pmc">PMC7313518</ArticleId><ArticleId IdType="pubmed">32592817</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi S., Pandey D.N., Singh R.H. COVID-19 pandemic: a pragmatic plan for ayurveda intervention. J. Ayurveda Integr. Med. 2020 doi: 10.1016/j.jaim.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaim.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7177084</ArticleId><ArticleId IdType="pubmed">32382220</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N.A., Kumar P., Kumar N. Spices and herbs: potential antiviral preventives and immunity boosters during COVID-19. Phytother. Res. PTR. 2021;35(5):2745&#x2013;2757. doi: 10.1002/ptr.7019. Jyoti.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7019</ArticleId><ArticleId IdType="pmc">PMC8013177</ArticleId><ArticleId IdType="pubmed">33511704</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X., Wang P., Su K., Cho W.C., Xing Y. Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis. Pharmacological research. 2020;160 doi: 10.1016/j.phrs.2020.105056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105056</ArticleId><ArticleId IdType="pmc">PMC7331568</ArticleId><ArticleId IdType="pubmed">32622723</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugraha R.V., Ridwansyah H., Ghozali M., Khairani A.F., Atik N. Traditional herbal medicine candidates as complementary treatments for covid-19: a review of their mechanisms, pros and cons. Evid. Based Complement. Altern. Med. 2020;2020:1&#x2013;12. doi: 10.1155/2020/2560645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/2560645</ArticleId><ArticleId IdType="pmc">PMC7569437</ArticleId><ArticleId IdType="pubmed">33101440</ArticleId></ArticleIdList></Reference><Reference><Citation>Paudyal V., Sun S., Hussain R., Abutaleb M.H., Hedima E.W. Complementary and alternative medicines use in COVID-19: a global perspective on practice, policy and research. Res. Soc. Adm. Pharm.: RSAP. 2022;18(3):2524&#x2013;2528. doi: 10.1016/j.sapharm.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8116135</ArticleId><ArticleId IdType="pubmed">33992585</ArticleId></ArticleIdList></Reference><Reference><Citation>Demeke C.A., Woldeyohanins A.E., Kifle Z.D. Herbal medicine use for the management of COVID 19: a review article. Metab. Open. 2021;12 doi: 10.1016/j.metop.2021.100141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2021.100141</ArticleId><ArticleId IdType="pmc">PMC8519661</ArticleId><ArticleId IdType="pubmed">34693242</ArticleId></ArticleIdList></Reference><Reference><Citation>O.C. Kurrian Expanding pharmaceutical local production in Africa: an idea whose time has come? Health express. 10 April. 2019. Available at: https://www.orfonline.org/expert-speak/expanding-pharmaceutical-local-production-in-africa-an-idea-whose-time-has-come-49805/. Accessed: 22 August, 2022.</Citation></Reference><Reference><Citation>Word Health Organization, (2013). WHO traditional medicine strategy: 2014-2023. https://www.who.int/publications/i/item/9789241506096 (accessed August, 24, 2022)</Citation></Reference><Reference><Citation>Siegfried N.L., Hughes G. Herbal medicine, randomized controlled trials and global core competencies. S. Afr. Med. J. 2021;102(12):912.</Citation><ArticleIdList><ArticleId IdType="pubmed">23498035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitsi G.M., Charles C.M., Gene D.M., Charles F.B.N. Capacity for ethical and regulatory review of herbal trials in developing countries: a case study of Moringa oleifera research in HIV-infected patients. J. Pharm. Policy Pract. 2017;10(9):1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322785</ArticleId><ArticleId IdType="pubmed">28250958</ArticleId></ArticleIdList></Reference><Reference><Citation>Willcox M., Siegfried N., Johnson Q. Capacity for clinical research on herbal medicines in Africa. J. Altern. Complement. Med. 2012;18(6):622&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3390968</ArticleId><ArticleId IdType="pubmed">22784350</ArticleId></ArticleIdList></Reference><Reference><Citation>A.D. Sharma &amp; I. Kaur (2021). Eucalyptus essential oil bioactive molecules from against SARS-CoV-2 spike protein: &amp; NBSP; insights from computational studies. 10.21203/rs.3.rs-140069/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-140069/v1</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>